Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003625171 | SCV004408927 | pathogenic | Alpha thalassemia-X-linked intellectual disability syndrome | 2023-01-15 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln811Serfs*11) in the ATRX gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ATRX are known to be pathogenic (PMID: 15591283, 18409179, 23681356). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ATRX-related conditions. For these reasons, this variant has been classified as Pathogenic. |